These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 5575570)
21. Effect of back passage of Venezuelan equine encephalomyelitis TC-83 vaccine virus on clinical, virologic, and immune responses in horses. Luedke AJ; Barber TL; Foster NM; Batalla D; Mercado S J Am Vet Med Assoc; 1972 Oct; 161(7):824-31. PubMed ID: 5074264 [No Abstract] [Full Text] [Related]
22. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Ferguson JA; Reeves WC; Milby MM; Hardy JL Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386 [TBL] [Abstract][Full Text] [Related]
23. Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis. Jochim MM; Barber TL J Am Vet Med Assoc; 1974 Oct; 165(7):621-5. PubMed ID: 4422323 [No Abstract] [Full Text] [Related]
25. The influence of infection with Venezuelan equine encephalomyelitis virus on antibody response against sheep erythrocytes. I. Experiments on mice. Hrusková J; Rychterová V; Kliment V Acta Virol; 1972 Mar; 16(2):115-24. PubMed ID: 4401068 [No Abstract] [Full Text] [Related]
26. Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in Equidae. Spertzel RO; Kahn DE J Am Vet Med Assoc; 1971 Sep; 159(6):731-8. PubMed ID: 5158756 [No Abstract] [Full Text] [Related]
27. Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines. I. Description and characterization of adoptive transfer by immune spleen cells. Rabinowitz SG J Infect Dis; 1976 Jul; 134(1):30-8. PubMed ID: 939921 [TBL] [Abstract][Full Text] [Related]
28. Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule. Rusnak JM; Dupuy LC; Niemuth NA; Glenn AM; Ward LA Comp Med; 2018 Oct; 68(5):380-395. PubMed ID: 30282570 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine. Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818 [TBL] [Abstract][Full Text] [Related]
30. Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to Eastern or Western Equine encephalitis virus, or both. Calisher CH; Sasso DR; Sather GE Appl Microbiol; 1973 Oct; 26(4):485-8. PubMed ID: 4751797 [TBL] [Abstract][Full Text] [Related]
31. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus]. Lukin EP; Chernikova NK Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525 [TBL] [Abstract][Full Text] [Related]
32. Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses. Pedersen CE J Clin Microbiol; 1976 Feb; 3(2):113-8. PubMed ID: 942635 [TBL] [Abstract][Full Text] [Related]
33. An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice. Brown A; Officer JE Arch Virol; 1975; 47(2):123-38. PubMed ID: 1119939 [TBL] [Abstract][Full Text] [Related]